Document Type : Original Research


1 Department of Gynecology and Obstetrics, Clinical Research Development Unit, Kosar Hospital, Qazvin University of Medical Sciences, Iran

2 Department of Gynecology and Obstetrics, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

3 Emergency Department, Kosar hospital, Qazvin University of Medical Sciences, Qazvin, Iran


Background & Objective: This study was designed to determine the prevalence of serotypes, virulence-associated genes, and antimicrobial resistance of Streptococcus agalactiae in pregnant volunteers attending a major maternity hospital in Iran.
Methods: The virulence determinants and antimicrobial resistance profiles of 270 Group B streptococcus (GBS) samples were assessed in the adult participants. The prevalence of GBS serotypes, virulence-associated genes, and antimicrobial resistance of the isolates was determined.
Results: The GBS prevalence in the vaginal, rectal, and urinal carrier rates were 8.9%, 4.44%, and 4.44%, respectively, with no concomitant colonization. The serotypes Ia, Ib, and II were at a 1:2:1 ratio. The rectal isolates, harboring CylE, lmb, and bca genes, were of serotype Ia, susceptible to vancomycin. The serotype Ib from urine samples carrying three distinct virulence genes was susceptible to Ampicillin. In comparison, the same serotype with two virulence genes of CylE and lmb exhibited sensitivity to both Ampicillin and Ceftriaxone. The vaginal isolates belonged to serotype II with the CylE gene or serotype Ib with CylE and lmb genes. These isolates harboring the CylE gene were resistant to Cefotaxime. The overall antibiotic susceptibility range was 12.5-56.25%.
Conclusion: The findings broaden our understanding of the pathogenicity of the prevailing GBS colonization and predict different clinical outcomes.


Main Subjects

  1. Ferreira M, de Paula GR, Barros RR. Distribution of virulence determinants in Streptococcus agalactiae recovered from different clinical sources. Microb Pathog. 2021;161(Pt A):105255. [DOI:10.1016/j.micpath.2021.105255] [PMID]
  2. Anderson KA, Schaefer AM, Rice CD. Quantifying circulating antibody activities against the emerging environmental pathogen, Streptococcus agalactiae, in wild captured bull sharks, spotted eagle rays, bottlenose dolphins, and loggerhead turtles. Fish Shellfish Immunol Rep. 2021;2:100024. [PMID] [PMCID] [DOI:10.1016/j.fsirep.2021.100024]
  3. Numberger D, Siebert U, Fulde M, Valentin-Weigand P. Streptococcal Infections in Marine Mammals. Microorganisms. 2021;9(2):350. [DOI:10.3390/microorganisms9020350] [PMID] [PMCID]
  4. Campo CH, Martinez MF, Otero JC, Rincon G. Vagino-rectal colonization prevalence by Streptococcus agalactiae and its susceptibility profile in pregnant women attending a third-level hospital. Biomedica. 2019;39(4):689-98. [DOI:10.7705/biomedica.4514] [PMID] [PMCID]
  5. Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019;7(2). [DOI:10.1128/microbiolspec.GPP3-0007-2018] [PMID] [PMCID]
  6. Bobadilla FJ, Novosak MG, Cortese IJ, Delgado OD, Laczeski ME. Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35-37 weeks of gestation. BMC Infect Dis. 2021;21(1):73. [DOI:10.1186/s12879-020-05603-5] [PMID] [PMCID]
  7. Committee Opinion No. 485: Prevention of Early-Onset Group B Streptococcal Disease in Newborns: Correction. Obstet Gynecol. 2018;131(2):397. [DOI:10.1097/AOG.0000000000002466] [PMID]
  8. Kannika K, Pisuttharachai D, Srisapoome P, Wongtavatchai J, Kondo H, Hirono I, et al. Molecular serotyping, virulence gene profiling and pathogenicity of Streptococcus agalactiae isolated from tilapia farms in Thailand by multiplex PCR. J Appl Microbiol. 2017;122(6):1497-507. [DOI:10.1111/jam.13447] [PMID]
  9. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. Wayne: CLSI; 2017.
  10. Hossein YektaKooshali M, Hamidi M, Mohammad Taghi Razavi Tousi S, Nikokar I. Prevalence of group B streptococcus colonization in Iranian pregnant women: A systematic review and meta-analysis. Int J Reprod BioMed. 2018;16(12). [DOI:10.18502/ijrm.v16i12.3679] [PMID] [PMCID]
  11. Lu B, Li D, Cui Y, Sui W, Huang L, Lu X. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China. Clin Microbiol Infect. 2014;20(6):O370-3. [DOI:10.1111/1469-0691.12416] [PMID]
  12. Kim EJ, Oh KY, Kim MY, Seo YS, Shin JH, Song YR, et al. Risk factors for group B streptococcus colonization among pregnant women in Korea. Epidemiol Health. 2011;33:e2011010. [DOI:10.4178/epih/e2011010] [PMID] [PMCID]
  13. Melo S, Costa AB, Silva F, Silva N, Tashima CM, Cardoso RF, et al. Prevalence of Streptococcus agalactiae colonization in pregnant women from the 18th Health Region of Parana State. Rev Inst Med Trop Sao Paulo. 2018;60:e2. [DOI:10.1590/s1678-9946201860002] [PMID] [PMCID]
  14. Lee WT, Lai MC. High prevalence of Streptococcus agalactiae from vaginas of women in Taiwan and its mechanisms of macrolide and quinolone resistance. J Microbiol Immunol Infect. 2015;48(5):510-6. [DOI:10.1016/j.jmii.2014.03.002] [PMID]
  15. Fazeli Z, Alipour M, Amir Mozafari N, Ghasemi Nejad Y, Salehi Omran O, Talebjanat M. The survey of Streptococcus agalactiae carriage in pregnant women and determination of antibiotics susceptibity pattern in Amol city. Iran J Med Microbiol. 2015;9(2):20-6.
  16. Sharmila V, Joseph NM, Arun Babu T, Chaturvedula L, Sistla S. Genital tract group B streptococcal colonization in pregnant women: a South Indian perspective. J Infect Dev Ctries. 2011;5(8):592-5. [DOI:10.3855/jidc.1551] [PMID]
  17. Assefa S, Desta K, Lema T. Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia. BMC Pregnancy Childbirth. 2018;18(1):135. [DOI:10.1186/s12884-018-1791-4] [PMID] [PMCID]
  18. Dashtizade M, Zolfaghari MR, Yousefi M, Nazari-Alam A. Antibiotic Susceptibility Patterns and Prevalence of Streptococcus Agalactiae Rectovaginal Colonization Among Pregnant Women in Iran. Rev Bras Ginecol Obstet. 2020;42(8):454-9. [DOI:10.1055/s-0040-1710299] [PMID]
  19. Nkembe NM, Kamga HG, Baiye WA, Chafa AB, Njotang PN. Streptococcus agalactiae prevalence and antimicrobial susceptibility pattern in vaginal and anorectal swabs of pregnant women at a tertiary hospital in Cameroon. BMC Res Notes. 2018;11(1):480. [DOI:10.1186/s13104-018-3589-x] [PMID] [PMCID]
  20. do Nascimento CS, Dos Santos NFB, Ferreira RCC, Taddei CR. Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance. Braz J Microbiol. 2019;50(4):943-52. [DOI:10.1007/s42770-019-00129-8] [PMID] [PMCID]
  21. Le Doare K, Jarju S, Darboe S, Warburton F, Gorringe A, Heath PT, et al. Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants. J Infect. 2016;72(3):283-94. [DOI:10.1016/j.jinf.2015.12.014] [PMID] [PMCID]
  22. Udo EE, Boswihi SS, Al-Sweih N. Genotypes and virulence genes in group B streptococcus isolated in the maternity hospital, Kuwait. Med Princ Pract. 2013;22(5):453-7. [DOI:10.1159/000349932] [PMID] [PMCID]
  23. Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016;9:351. [DOI:10.1186/s13104-016-2158-4] [PMID] [PMCID]
  24. Yasini M, Moniri R, Ghorbaali Z, Ansaripour L, Movahedinejad M, Yadegarsalehi MJmjomuoms. Prevalence rate, Antibiotic susceptibility and Colonization risk factors of Group B Streptococcus in genital tract of pregnant women. 2014;57(5):676-83.
  25. Wang P, Ma Z, Tong J, Zhao R, Shi W, Yu S, et al. Serotype distribution, antimicrobial resistance, and molecular characterization of invasive group B Streptococcus isolates recovered from Chinese neonates. Int J Infect Dis. 2015;37:115-8. [DOI:10.1016/j.ijid.2015.06.019] [PMID]